MELVILLE, N.Y. (AP) ¿ Bovie Medical Corp. said Tuesday it received clearance to sell a device that cuts and reseals tissue in kidney surgeries. The Food and Drug Administration approved market of Bovie's laparoscopic SEER device, which is used for cutting and coagulating soft tissue. It is intended to be used in partial removal of kidneys. Bovie said the laparoscopic SEER, or Saline Enhance Electrosurgical Resection, device is an extension of a line the company launched earlier this year. Bovie also said it filed for FDA approved of a line of coated blades and needles. The products are covered with a coating that resists scabbing and scar tissue caused by burning. The product line also includes coated ball electrodes. Shares of Bovie advanced 43 cents, or 5.4 percent, to $8.45 in afternoon trading.